Startups

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

Summary

Seedtable Score
  • 43
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
  • Series A

Total funding Amount

$42M

Fundraising History

  • Jun 01 '22 Series A
    $40M
  • Jan 01 '21 Unknown
    $2.5M

Investors

  • Hoxton Ventures
    Unknown
  • Bessemer Venture Partners
    Series A